Article PDF
Rights and permissions
About this article
Cite this article
Cost effectiveness of RSVIG therapy questioned. Pharmacoecon. Outcomes News 134, 9 (1997). https://doi.org/10.1007/BF03272108
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272108